Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- SourceOne Global Partners Provides Sytrinol Sub-Licensing Agreement To Soft Gel Technologies for U.S. Market
Company announces that it has provided Soft Gel Technologies, Inc. a sub-license agreement that allows SGTI to provide contract manufacturing services for Sytrinol in a soft gel delivery system for the U.S. market.
- SourceOne Global Partners Provides Sytrinol Sub-Licensing Agreement To Soft Gel Technologies for U.S. Market
Company announces that it has provided Soft Gel Technologies, Inc. a sub-license agreement that allows SGTI to provide contract manufacturing services for Sytrinol in a soft gel delivery system for the U.S. market.
- SourceOne Global Partners Provides Sytrinol Sub-Licensing Agreement To Soft Gel Technologies for U.S. Market
Company announces that it has provided Soft Gel Technologies, Inc. a sub-license agreement that allows SGTI to provide contract manufacturing services for Sytrinol in a soft gel delivery system for the U.S. market.
- SourceOne Global Partners Provides Sytrinol Sub-Licensing Agreement To Soft Gel Technologies for U.S. Market
Company announces that it has provided Soft Gel Technologies, Inc. a sub-license agreement that allows SGTI to provide contract manufacturing services for Sytrinol in a soft gel delivery system for the U.S. market.
- Kerry Announces Further Expansion of its North American Sweet Ingredients Business
Company announces acquisition of Custom Industries and Nuvex Ingredients for total consideration of US$83m.
- Kerry Announces Further Expansion of its North American Sweet Ingredients Business
Company announces acquisition of Custom Industries and Nuvex Ingredients for total consideration of US$83m.
- Kerry Announces Further Expansion of its North American Sweet Ingredients Business
Company announces acquisition of Custom Industries and Nuvex Ingredients for total consideration of US$83m.
- Kerry Announces Further Expansion of its North American Sweet Ingredients Business
Company announces acquisition of Custom Industries and Nuvex Ingredients for total consideration of US$83m.
- Kerry Announces Further Expansion of its North American Sweet Ingredients Business
Company announces acquisition of Custom Industries and Nuvex Ingredients for total consideration of US$83m.
- USANA Reports Record First Quarter Net Sales
Company reports Q1 net sales of $89.7 million, compared with $76.6 million in the first quarter of the prior year, with net earnings of $9.6 million compared with net earnings of $8.9 million in the first quarter of the prior year.
- USANA Reports Record First Quarter Net Sales
Company reports Q1 net sales of $89.7 million, compared with $76.6 million in the first quarter of the prior year, with net earnings of $9.6 million compared with net earnings of $8.9 million in the first quarter of the prior year.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- Nutri Pharmaceuticals Research Inc. Reports First Quarter Earnings
Company reports sales of $421,000 as compared to $290,000 in first quarter of the prior year, with profit approximated at$339,000, compared to $207,000 in same period of the prior year.
- Nutri Pharmaceuticals Research Inc. Reports First Quarter Earnings
Company reports sales of $421,000 as compared to $290,000 in first quarter of the prior year, with profit approximated at$339,000, compared to $207,000 in same period of the prior year.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- KGK Synergize Inc., Seeks Private Placement for Growth; JANUS CORPORATE FINANCE Retained as Principal Advisor
Company has retained Janus Corporate Finance to act as principal financial advisor in arranging additional growth capital for its emerging nutraceutical product technologies.
- KGK Synergize Inc., Seeks Private Placement for Growth; JANUS CORPORATE FINANCE Retained as Principal Advisor
Company has retained Janus Corporate Finance to act as principal financial advisor in arranging additional growth capital for its emerging nutraceutical product technologies.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Neptune Technologies & Bioressources Inc. Reports Third Quarter Results
Company reports revenues of $1,822,000 compared to $1,292,000 for the prior year, with a net profit of $1,038,000 or $0.032 per share for the quarter.
- Neptune Technologies & Bioressources Inc. Reports Third Quarter Results
Company reports revenues of $1,822,000 compared to $1,292,000 for the prior year, with a net profit of $1,038,000 or $0.032 per share for the quarter.
- EcoNugenics® Granted New U.S. Patent for Modified Pectin and Alginates
United States Patent and Trademark Office (USPTO) has issued the company US Patent No. 7,026,302.
- EcoNugenics® Granted New U.S. Patent for Modified Pectin and Alginates
United States Patent and Trademark Office (USPTO) has issued the company US Patent No. 7,026,302.
- EcoNugenics® Granted New U.S. Patent for Modified Pectin and Alginates
United States Patent and Trademark Office (USPTO) has issued the company US Patent No. 7,026,302.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 second quarter were $41.0 million compared to $38.8 million prior year, with net income of $5.0 million, or $0.43 diluted earnings per share, compared to $3.5 million, or $0.29 diluted earnings per share, for the same quarter of fiscal 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 second quarter were $41.0 million compared to $38.8 million prior year, with net income of $5.0 million, or $0.43 diluted earnings per share, compared to $3.5 million, or $0.29 diluted earnings per share, for the same quarter of fiscal 2005.
- Advitech Inc Announces Agreement with Enbio-Life for Dermylex in Taiwan
Company has announced that it has reached an agreement in principle regarding a marketing and distribution agreement for its Dermylex(TM) product with Taiwan-based Enbio-Life Biotechnology & Medical Company Ltd, ("Enbio-Life"), a subsidiary of Yusheng Pharma.
- Advitech Inc Announces Agreement with Enbio-Life for Dermylex in Taiwan
Company has announced that it has reached an agreement in principle regarding a marketing and distribution agreement for its Dermylex(TM) product with Taiwan-based Enbio-Life Biotechnology & Medical Company Ltd, ("Enbio-Life"), a subsidiary of Yusheng Pharma.
- NBTY Reports Second Quarter Results
Company reports net sales of $482 million compared to net sales of $443 million prior year, with $39 million increase including $32 million in net sales from NBTY's recent acquisitions: $26 million from Solgar, $3 million from LeNaturiste and $3 million from SISU. Net income was $21 million, or $0.31 per diluted share, compared to $21 million, or $0.30 per diluted share, for the fiscal second quarter ended March 31, 2005.
- NBTY Reports Second Quarter Results
Company reports net sales of $482 million compared to net sales of $443 million prior year, with $39 million increase including $32 million in net sales from NBTY's recent acquisitions: $26 million from Solgar, $3 million from LeNaturiste and $3 million from SISU. Net income was $21 million, or $0.31 per diluted share, compared to $21 million, or $0.30 per diluted share, for the fiscal second quarter ended March 31, 2005.
- Phosphagenics & Nestle Nutrition Sign Agreement for Development of Phospha E(R) for Foods and Beverages
Phosphagenics Limited and Nestle Nutrition, a unit of Nestle S.A. have entered into a research agreement to develop Phosphagenics' Phospha E(R) for use in Nestle Nutrition's products.
- Phosphagenics & Nestle Nutrition Sign Agreement for Development of Phospha E(R) for Foods and Beverages
Phosphagenics Limited and Nestle Nutrition, a unit of Nestle S.A. have entered into a research agreement to develop Phosphagenics' Phospha E(R) for use in Nestle Nutrition's products.
- Phosphagenics & Nestle Nutrition Sign Agreement for Development of Phospha E(R) for Foods and Beverages
Phosphagenics Limited and Nestle Nutrition, a unit of Nestle S.A. have entered into a research agreement to develop Phosphagenics' Phospha E(R) for use in Nestle Nutrition's products.
- Natural Alternatives International, Inc. Announces Third Quarter Results
Company reports net income of $621,000 or $0.09 per diluted share compared to $277,000 or $0.04 per diluted share for the comparable quarter prior year, as net saloes increase from $22.5 million to $23.3 million, including net sales from recent acquisition Real Health Laboratories of $2.7 million for the quarter.
- Natural Alternatives International, Inc. Announces Third Quarter Results
Company reports net income of $621,000 or $0.09 per diluted share compared to $277,000 or $0.04 per diluted share for the comparable quarter prior year, as net saloes increase from $22.5 million to $23.3 million, including net sales from recent acquisition Real Health Laboratories of $2.7 million for the quarter.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Nu Skin Enterprises Reports First-Quarter 2006 Results
Company reports revenue of $265.8 million and a loss per share of $0.18 with net loss of $12.8 million and $0.18, compared to net income of $17.7 million and earnings per share of $0.25 during the first quarter of 2005.
- Nu Skin Enterprises Reports First-Quarter 2006 Results
Company reports revenue of $265.8 million and a loss per share of $0.18 with net loss of $12.8 million and $0.18, compared to net income of $17.7 million and earnings per share of $0.25 during the first quarter of 2005.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- The Hain Celestial Group Announces Third Quarter Sales and Earnings
Company reports sales of $196.4 million in its third quarter, compared to prior year's $161.3 million, with net income of $9.7 million, versus the prior year's $7.7 million.
- The Hain Celestial Group Announces Third Quarter Sales and Earnings
Company reports sales of $196.4 million in its third quarter, compared to prior year's $161.3 million, with net income of $9.7 million, versus the prior year's $7.7 million.
- SunOpta Announces First Quarter Results
Company reports revenues of $133,312,000 as compared to $86,223,000 in the first quarter of the prior year, led by a 52.5% increase in revenues within the Company's vertically integrated natural and organic food operations, with net income of $3,012,000 or $0.053 per diluted common share as compared to $6,605,000 or $0.116 per diluted common share in the prior year.
- SunOpta Announces First Quarter Results
Company reports revenues of $133,312,000 as compared to $86,223,000 in the first quarter of the prior year, led by a 52.5% increase in revenues within the Company's vertically integrated natural and organic food operations, with net income of $3,012,000 or $0.053 per diluted common share as compared to $6,605,000 or $0.116 per diluted common share in the prior year.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Green Bay, Wisconsin (April 26, 2006) –- EuroPharma is partnering with a European company to bring a new tablet coating technology to US companies. Products that utilize this technology and are now available through EuroPharma include a carb blocker, a fat blocker, and a blood sugar management supplement.
Bio-availability of these supplements has just been enhanced by Terry Lemerond’s latest European discovery. This new, patented tablet coating technology preserves active ingredients – allowing formula components to pass through the harsh gastric environment of the stomach. This new technology allows key ingredients to be better utilized by the body.
This new technology takes white kidney bean extract to a higher level of activity; making it 120 times stronger than other carb blockers currently on the market. This technology has also been utilized in a fat blocker product which improves lipase inhibition and blocks the absorption of fat. Research results with this fat blocker have demonstrated 71% lower serum triglycerides and 21% lower total cholesterol.
Another area of use with this new technology is with blood sugar management. In recent clinical research, subjects with Type 2 diabetes showed a 49% reduction in serum blood sugar levels.
“This new proprietary and patented enteric coating technology increases biological activity and ensures a greater amount of active ingredients reaching target areas of the body,” said EuroPharma’s founder Terry Lemerond.
EuroPharma has worldwide distribution rights for these products and is seeking partnerships with companies seeking to enhance their product offerings.
Located in Green Bay, Wisconsin, EuroPharma, Inc., is committed to discovering innovative products that have been extensively researched and demonstrated to be safe, natural and effective which will help people live healthier and more fulfilling lives. EuroPharma’s mission is to bring truly unique and industry changing products to the U.S. marketplace. EuroPharma is an extension of its founder, Terry Lemerond’s historic successes and a proven model of product development. For more information, visit www.EuroPharmaUSA.com or contact Lisa Joski, Ljoski@EuroPharmaUSA.com, 920-406-6506.
– END – |